ChemoCentryx
CCXI
#3639
Rank
NZ$6.20 B
Marketcap
NZ$86.32
Share price
0.00%
Change (1 day)
23.66%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: NZ$6.20 Billion

On November 25, 2022 ChemoCentryx had a market cap of NZ$6.20 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$5.88 B57.76%
2021NZ$3.73 B-37.15%
2020NZ$5.93 B67.9%
2019NZ$3.53 B329.36%
2018NZ$0.82 B101.65%
2017NZ$0.40 B-20%
2016NZ$0.51 B-2.34%
2015NZ$0.52 B38.08%
2014NZ$0.37 B25.33%
2013NZ$0.30 B-37.5%
2012NZ$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$909.08 B 14,542.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$249.60 B 3,920.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$654.43 B 10,441.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$305.67 B 4,823.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$43.81 B 605.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$457.32 B 7,266.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$186.07 B 2,897.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$173.15 B 2,689.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$64.92 B 945.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel